Flavor Enhancers Bypassing French Ban Raise Concerns

Regulations by 2FIRSTS.ai

Jan.24.2024

Flavor Enhancers Bypassing French Ban Raise Concerns

E-cigarette industry faces concerns over potential risks as it circumvents tobacco flavoring ban through sale of 'flavor enhancers'.

According to reports from French media, the e-cigarette industry has recently been exposed for engaging in a potentially risky market practice by circumventing the ban on flavored vaping products through the sale of so-called "flavor enhancers". This practice has raised concerns over the respiratory health of users, particularly the allure it may hold for young people.

According to Mathieu Morissette, a researcher at the Quebec University Heart and Lung Research Institute, the sale of these flavor enhancers involves circumventing regulations. The e-cigarette industry has successfully bypassed the regulations banning the direct sale of flavored e-cigarette products by selling unflavored base liquids and providing additional flavor enhancers.

During an interview with host Paul Arcand, Morissette pointed out that the motive behind this action could potentially be the tobacco industry's attempt to attract new users.

The industry's such circumvention of regulations may have profound implications for public health, and it has already garnered widespread concern among young people.

References:

[1] L'industrie du vapotage contourne la loi sur les saveurs

Also Read:

[1] Rising Tobacco Prices in France Fuel Concerns of Illegal Trade

[2] Gabriel Attal: Ambitious and Energetic New French Prime Minister

[3] France Parliament Unanimously Passes Bill to Ban Disposable E-Cigarettes

#Europe #Legislation #Open system e-cigarettes #France #Legislation France #E-cigarettes with Flavors

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Lawmakers Seek to Empower HHS to Destroy Counterfeit Chinese Tobacco Products

Bipartisan members of the U.S. Congress have introduced the “Ensuring the Necessary Destruction of Illicit Chinese Tobacco Act” (END Act), seeking to amend the Federal Food, Drug, and Cosmetic Act to authorize the Department of Health and Human Services (HHS) to directly destroy adulterated, misbranded, or counterfeit imported tobacco products.Major tobacco companies, including Altria, along with several public health organizations, have announced their support for the bill.

Nov.11 by 2FIRSTS.ai

ZYN Nicotine Pouches Seek MRTP Authorization; FDA Sets January Meeting

The U.S. FDA has scheduled a Tobacco Products Scientific Advisory Committee (TPSAC) meeting for January 22, 2026, to review Swedish Match USA’s Modified Risk Tobacco Product (MRTP) applications for 20 ZYN nicotine pouch products. Although the products gained PMTA authorization in early 2025, MRTP approval is required for marketing them with reduced-risk claims.

Nov.24 by 2FIRSTS.ai

U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned

Turning Point Brands (NYSE: TPB) released its financial results for the third quarter of 2025, reporting strong revenue and profit growth driven by surging Modern Oral (nicotine pouch) sales. The company announced plans to establish its first U.S.-based white pouch production line in 2026, marking a key step toward manufacturing localization.

Nov.06 by 2FIRSTS.ai

UK’s Nationwide Crackdown Seizes 111,000 Illegal Vapes in “Machinize 2” Operation

UK police have carried out a nationwide crackdown under Operation Machinize 2, targeting illegal vapes, counterfeit goods, and grey-market businesses. Raids on more than 2,700 premises led to 924 arrests and the seizure of 111,000 illegal vapes, 70kg of cannabis, 4.5m cigarettes, and £10.7m in proceeds.